Impact of age, sex, ethnicity, socio‐economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand-Reference-Cited by-同舟云学术

Impact of age, sex, ethnicity, socio‐economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand

Published:2019-10-04 Issue:5 Volume:188 Page:692-700
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Chan Henry S. H.¹²^ORCID,Milne Richard J.³⁴

Affiliation:

1. Department of Haematology Waitemata District Health Board Auckland New Zealand

2. Faculty of Medical and Health Sciences The University of Auckland Auckland New Zealand

3. Health Outcomes Associates Ltd Auckland New Zealand

4. School of Pharmacy The University of Auckland Auckland New Zealand

Funder

Myeloma New Zealand

Janssen New Zealand

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16238

Reference39 articles.

1. Ahmad O.B. Boschi Pinto C.&Lopez A.D.(2001)Age Standardization of Rates: A New WHO Standard. GPE Discussion Paper Series EIP/GPE/EBD No.31.World Health Organization Geneva.

2. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

3. Australian Institute of Health and Welfare. (2017)Cancer in Australia 2017. Cancer series no. 101. Cat. No. CAN 100.AIHW Canberra.

4. Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020;Cancer Biology & Medicine;2024-07-11

2. Global disparities in patients with multiple myeloma: a rapid evidence assessment;Blood Cancer Journal;2023-07-18

3. Global burden of hematologic malignancies and evolution patterns over the past 30 years;Blood Cancer Journal;2023-05-17

4. Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population‐based cohort study;American Journal of Hematology;2023-05-16

5. Socioeconomic status-based survival disparities and nomogram prediction for patients with multiple myeloma: Results from American and Chinese populations;Frontiers in Oncology;2022-08-26